Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
35 Results for "
Streptococcus faecalis
" in MedChemExpress (MCE) Product Catalog:
Products (35)
35 Results for "Streptococcus faecalis" in MCE Product Catalog:
11
Target:
Cefuroxime is an orally active second-generation cephalosporin antibiotic with increased stability to β-lactamase. Cefuroxime has a broad spectrum activity against Gram-positive and Gram-negative bacteria .
11
11 Publications Verification
AMXT-1501 is a Bacterial agent and polyamine transport system inhibitor. AMXT-1501 targets membrane phospholipids and exhibits antibacterial activity against a variety of Gram-positive and Gram-negative multidrug-resistant bacteria . AMXT-1501 inhibits capsular biosynthesis in Streptococcus pneumoniae . AMXT-1501 targets ornithine decarboxylase and polyamines to inhibit the proliferation of neuroblastoma cells . AMXT-1501 in combination with DFMO (HY-B0744) induces Apoptosis in neuroblastoma cells. AMXT-1501 is applicable to research related to multidrug-resistant bacterial infections, pneumococcal infections, Streptococcus pneumoniae infections, and neuroblastoma .
11
11 Publications Verification
Cat. No.: HY-B1256
CAS No.: 56238-63-2
Target:
Cefuroxime sodium is an orally active second-generation cephalosporin antibiotic with increased stability to β-lactamase. Cefuroxime sodium has a broad spectrum activity against Gram-positive and Gram-negative bacteria .
8
Cat. No.: HY-N10264
CAS No.: 269741-97-1
Synonyms: (+)-Avrainvillamide; CJ-17,665
Category:
Infection Alkaloids Microorganisms Pyrrole Alkaloids Disease Research Fields Indole Alkaloids
Target:
Cat. No.: HY-N13668
CAS No.: 468757-69-9
Category:
Target:
Cat. No.: HY-B0771A
CAS No.: 113981-44-5
Synonyms: SCE-2787 hydrochloride
Research Areas:
Cefozopran (SCE-2787) hydrochloride is a potent antibiotic with broad-spectrum antibacterial activity. Cefozopran hydrochloride binds PBPs, induces cell wall destruction, cell elongation, filamentation, irregular septa formation, and bactericidal, bacteriolytic activity. Cefozopran hydrochloride reduces bacterial counts and eradicates bacteria in mouse respiratory, urinary, and thigh muscle infections. Cefozopran hydrochloride can be used for the research of bacterial infections .
Research Areas:
10-Formylfolic acid is a potent inhibitor of dihydrofolate reductase, with an IC50 of 80 nM against the rat enzyme. 10-Formylfolic acid also acts as an orally active folate source and a growth factor for specific bacteria. 10-Formylfolic acid supports growth and increases plasma folate levels; its absorption and metabolism patterns are similar to those of folic acid, but its liver retention is slightly higher. It exhibits high folate activity in microbial assays, serves as a growth factor for Enterococcus faecalis and Lactobacillus casei, aids folate nutrient supply, and may exert cell regulatory functions .
Cat. No.: HY-W587957
CAS No.: 5143-05-5
Gypsogenic acid is a triterpenoid acid that can be isolated from Miconia stenostachya and has antibacterial and trypanoidal activities. The MICs values of Gypsogenic acid for the oral bacterial pathogens Enterococcus faecalis, Streptococcus salivarius, Streptococcus haematococcus, Streptococcus mutans and sobrinus were 50-200 μg/mL. Gypsogenic acid can induce blood cortensite cleavage in isolated mice with IC50 56.6 μM .
Target:
Cat. No.: HY-B0771
CAS No.: 113359-04-9
Synonyms: SCE-2787
Research Areas:
Cefozopran (SCE-2787) is a potent antibiotic with broad-spectrum antibacterial activity. Cefozopran binds PBPs, induces cell wall destruction, cell elongation, filamentation, irregular septa formation, and bactericidal, bacteriolytic activity. Cefozopran reduces bacterial counts and eradicates bacteria in mouse respiratory, urinary, and thigh muscle infections. Cefozopran can be used for the research of bacterial infections .
Cat. No.: HY-P10996
Synonyms: Human Neutrophil Peptide-4 TFA
Cat. No.: HY-178952
Anti-infective agent 12 (Compound A09) is a competitive inhibitor of type I signal peptidease (SPase I), with an IC50 of 4.475 μM and a Kd of 16.3 μM. Anti-infective agent 12 has the ability to disrupt bacterial membranes and remove biofilms. Anti-infective agent 12 exhibits potent bactericidal activity against Gram-positive bacteria, with MIC values of 4, 4, 8, and 8 μg/mL for Staphylococcus aureus, Enterococcus faecalis, Enterococcus faecium, and Streptococcus suis, respectively. Anti-infective agent 12 remains effective against multi-drug resistant strains, but has weaker activity against Gram-negative bacteria (such as Escherichia coli and Salmonella), with MIC values > 64 μg/mL. Anti-infective agent 12 has low hemolytic activity and shows significant efficacy in mouse skin infection models .
Cat. No.: HY-105213
CAS No.: 127521-69-1
Synonyms: MC-352
Target:
Research Areas:
YM-17K (MC-352) is a macrolide antibiotic. YM-17K exhibits antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria, and anaerobic bacteria. YM-17K exhibits stable activity in serum and is less affected by pH values .
Cat. No.: HY-E70939
Target:
Research Areas:
L-Phenylalanine decarboxylase, Streptococcus faecalis (EC 4.1.1.53) belongs to the lyase family and is capable of cleaving carbon-carbon bonds. L-Phenylalanine decarboxylase, Streptococcus faecalis is involved in the metabolism of phenylalanine. This enzyme has one substrate, L-phenylalanine, and two products: phenylethylamine and CO2.
Cat. No.: HY-N14367
CAS No.: 50355-67-4
Category:
Target:
Cat. No.: HY-126806
CAS No.: 88912-57-6
Target:
Research Areas:
Pyrrofolic acid is a folate antagonist with a low activity as a folate antagonist for Streptococcus faecalis .
Cat. No.: HY-P2825A
Target:
Research Areas:
L-Tyrosine Decarboxylase, Streptococcus faecalis (EC 4.1.1.25), is a carboxyl lyase capable of cleaving carbon-carbon bonds. L-Tyrosine Decarboxylase Apoenzyme participates in tyrosine metabolism and alkaloid biosynthesis. L-Tyrosine Decarboxylase Apoenzyme uses a cofactor—pyridoxal phosphate. L-Tyrosine Decarboxylase Apoenzyme has one substrate, L-tyrosine, and two products: tyramine and carbon dioxide.
Cat. No.: HY-E70938
Target:
Research Areas:
L-Tyrosine Decarboxylase Apoenzyme, Streptococcus faecalis (EC 4.1.1.25), is a carboxyl lyase capable of cleaving carbon-carbon bonds. L-Tyrosine Decarboxylase Apoenzyme participates in tyrosine metabolism and alkaloid biosynthesis. L-Tyrosine Decarboxylase Apoenzyme uses a cofactor—pyridoxal phosphate. L-Tyrosine Decarboxylase Apoenzyme has one substrate, L-tyrosine, and two products: tyramine and carbon dioxide.
Cat. No.: HY-N5184
CAS No.: 256230-47-4
Synonyms: Nocathiacine III
Category:
Target:
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
